Artikel baserad på Infant Bacterial Therapeutics “Connection Study” publicerad i British Journal of Gastroenterology visar att en dags minskning av tiden till “Sustained Feeding Tolerance (SFT)” korrelerar med klinisk meningsfulla resultat
November 01, 2022 03:00 ET
|
Infant Bacterial Therapeutics AB
Infant Bacterial Therapeutics (IBT) "Connection Study" består av två oberoende primära endpoints, förekomsten av NEC och tiden tills man når SFT. SFT ett sammansatt effektmått definierat som den...
Article based on Infant Bacterial Therapeutics’ (IBT) Connection Study published in the British Journal of Gastroenterology demonstrates that one day shift in Sustained Feeding Tolerance (SFT) correlates to clinically meaningful outcomes.
November 01, 2022 03:00 ET
|
Infant Bacterial Therapeutics AB
The two independent primary endpoints of the ‘Connection Study’ are the incidence of NEC and the time to SFT. SFT a composite endpoint defined as the first day of tolerating daily enteral feeds of...